Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyCellularComponent	super elongation complex	EAF2 AFF3	2.09e-04	6	79	2	GO:0032783
Domain	IPT	PLXNA4 PKHD1 REL PLXNA2	3.92e-06	27	75	4	SM00429
Domain	TIG	PLXNA4 PKHD1 REL PLXNA2	6.95e-06	31	75	4	PF01833
Domain	IPT	PLXNA4 PKHD1 REL PLXNA2	7.92e-06	32	75	4	IPR002909
Domain	ZF_CCHC_HIVEP	HIVEP3 HIVEP1	1.59e-05	2	75	2	PS51811
Domain	DUF3398	DOCK8 DOCK7	2.36e-04	6	75	2	PF11878
Domain	DOCK_C/D_N	DOCK8 DOCK7	2.36e-04	6	75	2	IPR021816
Domain	TB	LTBP2 FBN3	3.30e-04	7	75	2	PF00683
Domain	-	LTBP2 FBN3	4.39e-04	8	75	2	3.90.290.10
Domain	Plexin_cytopl	PLXNA4 PLXNA2	5.62e-04	9	75	2	PF08337
Domain	Plexin_cytoplasmic_RasGAP_dom	PLXNA4 PLXNA2	5.62e-04	9	75	2	IPR013548
Domain	Plexin	PLXNA4 PLXNA2	5.62e-04	9	75	2	IPR031148
Domain	TB	LTBP2 FBN3	5.62e-04	9	75	2	PS51364
Domain	TB_dom	LTBP2 FBN3	5.62e-04	9	75	2	IPR017878
Domain	Ig_E-set	PLXNA4 PKHD1 REL PLXNA2	8.14e-04	104	75	4	IPR014756
Domain	DOCK_C	DOCK8 DOCK7	8.55e-04	11	75	2	IPR010703
Domain	DHR-1_domain	DOCK8 DOCK7	8.55e-04	11	75	2	IPR027007
Domain	DHR_2	DOCK8 DOCK7	8.55e-04	11	75	2	PS51651
Domain	DHR_1	DOCK8 DOCK7	8.55e-04	11	75	2	PS51650
Domain	DOCK-C2	DOCK8 DOCK7	8.55e-04	11	75	2	PF14429
Domain	DHR-2	DOCK8 DOCK7	8.55e-04	11	75	2	IPR027357
Domain	DHR-2	DOCK8 DOCK7	8.55e-04	11	75	2	PF06920
Domain	DOCK	DOCK8 DOCK7	8.55e-04	11	75	2	IPR026791
Domain	-	IL31RA TRIO PLXNA4 PKHD1 REL LRRC4B LRRC4C HCFC1 PLXNA2	1.32e-03	663	75	9	2.60.40.10
Domain	Ig-like_fold	IL31RA TRIO PLXNA4 PKHD1 REL LRRC4B LRRC4C HCFC1 PLXNA2	2.03e-03	706	75	9	IPR013783
Domain	-	RNF19A PHF11 BARD1 RIMS1 NEURL1B KAT6B MDM4	2.15e-03	449	75	7	3.30.40.10
Domain	Znf_RING/FYVE/PHD	RNF19A PHF11 BARD1 RIMS1 NEURL1B KAT6B MDM4	2.43e-03	459	75	7	IPR013083
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	CEP350 RAPGEF6 AMER1 HIVEP1 OFD1 TRIO SEC16A DOCK7 ANKRD17 ITPRID2 CCDC6 MDM4 TRAK1 FAM110B	9.72e-09	861	80	14	36931259
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	CEP350 RAPGEF6 OFD1 TRIO SEC16A DOCK7 CCDC6 TRAK1	2.97e-08	209	80	8	36779422
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	RAPGEF6 HIVEP1 ARID4B SEC16A SENP6 KIAA1958 ANKRD17 RIMS1 ITPRID2 GPATCH8 CCDC6 KAT6B	2.05e-07	774	80	12	15302935
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	PCNX2 HIVEP3 THADA AMER1 TRIO AFF3 BARD1 ANKRD17 RIMS1 ZSWIM1 MBD5 KAT6B LARP4 MDM4 SCARA3	1.34e-06	1489	80	15	28611215
Pubmed	Genome-wide association study of primary dentition pit-and-fissure and smooth surface caries.	ANKRD17 IRAK3 OC90 FAM110B	2.01e-06	39	80	4	24556642
Pubmed	NGL-3 in the regulation of brain development, Akt/GSK3b signaling, long-term depression, and locomotive and cognitive behaviors.	LRRC4B LRRC4C	5.23e-06	2	80	2	31166939
Pubmed	Regulation of human immunodeficiency virus enhancer function by PRDII-BF1 and c-rel gene products.	HIVEP1 REL	5.23e-06	2	80	2	1727488
Pubmed	LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.	TRIO SEC16A DOCK7 ANKRD17 SRPK1 ITPRID2	7.49e-06	202	80	6	33005030
Pubmed	Plexin-A3 mediates semaphorin signaling and regulates the development of hippocampal axonal projections.	RELN PLXNA4 PLXNA2	7.79e-06	17	80	3	11683995
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	ZC3H7A HIVEP1 ZGRF1 ZNF180 SEC16A SENP6 ITPRID2 CCDC6 MDM4	8.48e-06	588	80	9	38580884
Pubmed	BioID-based Identification of Skp Cullin F-box (SCF)β-TrCP1/2 E3 Ligase Substrates.	AMER1 HIVEP1 OFD1 REL GPATCH8 HCFC1	1.42e-05	226	80	6	25900982
Pubmed	Structural Basis for Plexin Activation and Regulation.	PLXNA4 PLXNA2	1.57e-05	3	80	2	27397516
Pubmed	Interactions between plexin-A2, plexin-A4, and semaphorin 6A control lamina-restricted projection of hippocampal mossy fibers.	PLXNA4 PLXNA2	1.57e-05	3	80	2	17296555
Pubmed	Repulsive and attractive semaphorins cooperate to direct the navigation of cardiac neural crest cells.	PLXNA4 PLXNA2	1.57e-05	3	80	2	18625214
Pubmed	RNF19A-mediated ubiquitination of BARD1 prevents BRCA1/BARD1-dependent homologous recombination.	RNF19A BARD1	1.57e-05	3	80	2	34789768
Pubmed	Role of transmembrane semaphorin Sema6A in oligodendrocyte differentiation and myelination.	PLXNA4 PLXNA2	1.57e-05	3	80	2	22777942
Pubmed	Mispositioned Neurokinin-1 Receptor-Expressing Neurons Underlie Heat Hyperalgesia in Disabled-1 Mutant Mice.	RELN TACR1	1.57e-05	3	80	2	31122949
Pubmed	Human Immunodeficiency Virus Type 1 Vpr Mediates Degradation of APC1, a Scaffolding Component of the Anaphase-Promoting Complex/Cyclosome.	CEP350 OFD1 GCLM ANKRD17 ITPRID2 CDKAL1	2.08e-05	242	80	6	34011540
Pubmed	Chromosome assignment of four plexin A genes (Plxna1, Plxna2, Plxna3, Plxna4) in mouse, rat, Syrian hamster and Chinese hamster.	PLXNA4 PLXNA2	3.13e-05	4	80	2	11306810
Pubmed	PlexinA polymorphisms mediate the developmental trajectory of human corpus callosum microstructure.	PLXNA4 PLXNA2	3.13e-05	4	80	2	25518740
Pubmed	A mammalian homolog of Drosophila schnurri, KRC, regulates TNF receptor-driven responses and interacts with TRAF2.	HIVEP3 TNFRSF1B	3.13e-05	4	80	2	11804591
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	PCNX2 HIVEP3 THADA RAPGEF6 OFD1 TRIO SEC16A MBD5 SCARA3 HCFC1 TRAK1	4.48e-05	1105	80	11	35748872
Pubmed	A CRISPR-based screen for Hedgehog signaling provides insights into ciliary function and ciliopathies.	ARID4B TRIO LRRCC1 NEURL1B PZP HCFC1	5.09e-05	284	80	6	29459677
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	RAPGEF6 HIVEP1 ZGRF1 SEC16A DOCK7 KIAA1958 ANKRD17	5.15e-05	418	80	7	34709266
Pubmed	Guidance-cue control of horizontal cell morphology, lamination, and synapse formation in the mammalian outer retina.	PLXNA4 PLXNA2	5.20e-05	5	80	2	22593055
Pubmed	Regulation of Cardiac Mast Cell Maturation and Function by the Neurokinin-1 Receptor in the Fibrotic Heart.	TACR1 TNFRSF1B	5.20e-05	5	80	2	31358823
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	RAPGEF6 AMER1 OFD1 DOCK8 SEC16A DOCK7 CCDC6	7.72e-05	446	80	7	24255178
Pubmed	Semaphorin-Plexin signaling influences early ventral telencephalic development and thalamocortical axon guidance.	PLXNA4 PLXNA2	7.79e-05	6	80	2	28438183
Pubmed	Roles of semaphorin-6B and plexin-A2 in lamina-restricted projection of hippocampal mossy fibers.	PLXNA4 PLXNA2	7.79e-05	6	80	2	20484647
Pubmed	Nbeal2 interacts with Dock7, Sec16a, and Vac14.	SEC16A DOCK7	7.79e-05	6	80	2	29187380
Pubmed	Absence of tumor necrosis factor rescues RelA-deficient mice from embryonic lethality.	REL TNFRSF1B	7.79e-05	6	80	2	10077625
Pubmed	Human transcription factor protein interaction networks.	EPC2 EYA4 HIVEP1 ARID4B OFD1 SEC16A ANKRD17 REL GPATCH8 LARP4 ATXN1L HCFC1	1.00e-04	1429	80	12	35140242
Pubmed	Semaphorin-6A controls guidance of corticospinal tract axons at multiple choice points.	PLXNA4 PLXNA2	1.09e-04	7	80	2	19063725
Pubmed	Increased proximal bifurcation of CA1 pyramidal apical dendrites in sema3A mutant mice.	PLXNA4 PLXNA2	1.09e-04	7	80	2	19655386
Pubmed	LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells.	CEP350 AMER1 SEC16A DOCK7 ANKRD17 GPATCH8 CCDC6 ADGRG4	1.13e-04	639	80	8	23443559
Pubmed	Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation.	DOCK7 PKHD1 SENP6 ANKRD17 RIMS1	1.22e-04	208	80	5	33230847
Pubmed	ING tumor suppressor proteins are critical regulators of chromatin acetylation required for genome expression and perpetuation.	EPC2 ARID4B KAT6B	1.26e-04	42	80	3	16387653
Pubmed	A human MAP kinase interactome.	CEP350 ZC3H7A HIVEP1 ARID4B ANKRD17 ITPRID2 MBD5	1.31e-04	486	80	7	20936779
Pubmed	A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.	CEP350 ZC3H7A RAPGEF6 AMER1 EAF2 SEC16A DOCK7 REL CCDC6 TRAK1	1.33e-04	1038	80	10	26673895
Pubmed	The expression of plexins during mouse embryogenesis.	PLXNA4 PLXNA2	1.45e-04	8	80	2	15661641
Pubmed	Integration of opposing semaphorin guidance cues in cortical axons.	PLXNA4 PLXNA2	1.45e-04	8	80	2	22368082
Pubmed	Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci.	THADA REL PTGER4 CDKAL1	1.53e-04	116	80	4	21102463
Pubmed	Interaction network of human early embryonic transcription factors.	EPC2 EYA4 HIVEP1 ARID4B SEC16A ATXN1L	1.62e-04	351	80	6	38297188
Pubmed	Semaphorin 6A in Retinal Ganglion Cells Regulates Functional Specialization of the Inner Retina.	PLXNA4 PLXNA2	1.86e-04	9	80	2	38014224
Pubmed	The role of neuropilins in cell signalling.	PLXNA4 PLXNA2	1.86e-04	9	80	2	19909241
Pubmed	The MYO6 interactome reveals adaptor complexes coordinating early endosome and cytoskeletal dynamics.	OFD1 DOCK8 SEC16A DOCK7	2.04e-04	125	80	4	29467281
Pubmed	Substrate trapping proteomics reveals targets of the βTrCP2/FBXW11 ubiquitin ligase.	FOXN2 AMER1 HIVEP1 HCFC1	2.23e-04	128	80	4	25332235
Pubmed	Plexin A3 and plexin A4 convey semaphorin signals during facial nerve development.	PLXNA4 PLXNA2	2.32e-04	10	80	2	18804103
Pubmed	The deubiquitinating enzyme BAP1 regulates cell growth via interaction with HCF-1.	ANKRD17 HCFC1	2.32e-04	10	80	2	19815555
Pubmed	An extracellular biochemical screen reveals that FLRTs and Unc5s mediate neuronal subtype recognition in the retina.	PLXNA4 LRRC4C PLXNA2	2.39e-04	52	80	3	26633812
Pubmed	Hoxb8 intersection defines a role for Lmx1b in excitatory dorsal horn neuron development, spinofugal connectivity, and nociception.	RELN TACR1	2.84e-04	11	80	2	25834049
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	CEP350 ZC3H7A TRIO SEC16A GPATCH8 LARP4 HCFC1 CDKAL1	2.86e-04	733	80	8	34672954
Pubmed	Functional loss of semaphorin 3C and/or semaphorin 3D and their epistatic interaction with ret are critical to Hirschsprung disease liability.	PLXNA4 PLXNA2	3.40e-04	12	80	2	25839327
Pubmed	De novo genic mutations among a Chinese autism spectrum disorder cohort.	HIVEP3 RIMS1	3.40e-04	12	80	2	27824329
Pubmed	PLXNA1 and PLXNA3 cooperate to pattern the nasal axons that guide gonadotropin-releasing hormone neurons.	PLXNA4 PLXNA2	3.40e-04	12	80	2	31690636
Pubmed	On and off retinal circuit assembly by divergent molecular mechanisms.	PLXNA4 PLXNA2	3.40e-04	12	80	2	24179230
Pubmed	Deletion of Sema3a or plexinA1/plexinA3 causes defects in sensory afferent projections of statoacoustic ganglion neurons.	PLXNA4 PLXNA2	3.40e-04	12	80	2	23991118
Pubmed	NGL family PSD-95-interacting adhesion molecules regulate excitatory synapse formation.	LRRC4B LRRC4C	3.40e-04	12	80	2	16980967
Pubmed	Transcriptome profiling reveals expression signatures of cranial neural crest cells arising from different axial levels.	PLXNA4 PLXNA2	3.40e-04	12	80	2	28407732
Pubmed	Transmembrane semaphorin signalling controls laminar stratification in the mammalian retina.	PLXNA4 PLXNA2	3.40e-04	12	80	2	21270798
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SEC16A DOCK7 LRRC4C GPATCH8 PLXNA2 TRAK1	3.59e-04	407	80	6	12693553
Pubmed	Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signalling.	AFF3 DOCK7 REL RIMS1 FAM110B	3.73e-04	265	80	5	19240061
Pubmed	Functional assembly of accessory optic system circuitry critical for compensatory eye movements.	PLXNA4 PLXNA2	4.01e-04	13	80	2	25959730
Pubmed	Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebrates.	PLXNA4 PLXNA2	4.01e-04	13	80	2	10520995
Pubmed	Plexin signaling via off-track and rho family GTPases.	PLXNA4 PLXNA2	4.01e-04	13	80	2	11604131
Pubmed	Semaphorin3A, Neuropilin-1, and PlexinA1 are required for lymphatic valve formation.	PLXNA4 PLXNA2	4.01e-04	13	80	2	22723296
Pubmed	A set of proteins interacting with transcription factor Sp1 identified in a two-hybrid screening.	RNF19A HCFC1	4.67e-04	14	80	2	10976766
Pubmed	A midline switch of receptor processing regulates commissural axon guidance in vertebrates.	PLXNA4 PLXNA2	4.67e-04	14	80	2	20159958
Pubmed	Identification of an evolutionarily conserved superfamily of DOCK180-related proteins with guanine nucleotide exchange activity.	DOCK8 DOCK7	4.67e-04	14	80	2	12432077
Pubmed	E3 ligases determine ubiquitination site and conjugate type by enforcing specificity on E2 enzymes.	BARD1 MDM4	5.38e-04	15	80	2	21965653
Pubmed	Tat predominantly associates with host promoter elements in HIV-1-infected T-cells - regulatory basis of transcriptional repression of c-Rel.	REL HCFC1	5.38e-04	15	80	2	25472883
Pubmed	In the developing cerebral cortex: axonogenesis, synapse formation, and synaptic plasticity are regulated by SATB2 target genes.	PLXNA4 PLXNA2	5.38e-04	15	80	2	36028553
Pubmed	Allocation of paraventricular and supraoptic neurons requires Sim1 function: a role for a Sim1 downstream gene PlexinC1.	PLXNA4 PLXNA2	6.14e-04	16	80	2	17356169
Pubmed	Optic chiasm presentation of Semaphorin6D in the context of Plexin-A1 and Nr-CAM promotes retinal axon midline crossing.	PLXNA4 PLXNA2	6.14e-04	16	80	2	22632726
Pubmed	Expression of the semaphorins Sema 3D and Sema 3F in the developing parathyroid and thymus.	PLXNA4 PLXNA2	6.14e-04	16	80	2	18489001
Pubmed	Genome wide association (GWA) predictors of anti-TNFalpha therapeutic responsiveness in pediatric inflammatory bowel disease.	PTGER4 CDKAL1	6.14e-04	16	80	2	20014019
Pubmed	Association of common type 2 diabetes risk gene variants and posttransplantation diabetes mellitus in renal allograft recipients in Korea.	THADA CDKAL1	6.95e-04	17	80	2	19741467
Pubmed	Semaphorin signaling facilitates cleft formation in the developing salivary gland.	PLXNA4 PLXNA2	6.95e-04	17	80	2	17626059
Pubmed	Association of 18 confirmed susceptibility loci for type 2 diabetes with indices of insulin release, proinsulin conversion, and insulin sensitivity in 5,327 nondiabetic Finnish men.	THADA CDKAL1	6.95e-04	17	80	2	19502414
Pubmed	Transferability of type 2 diabetes implicated loci in multi-ethnic cohorts from Southeast Asia.	PCNX2 CDKAL1	6.95e-04	17	80	2	21490949
Pubmed	Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.	CEP350 EPC2 ARID4B OFD1 SEC16A DOCK7 BARD1	7.20e-04	645	80	7	25281560
Pubmed	Quantitative proteomic profiling of the extracellular matrix of pancreatic islets during the angiogenic switch and insulinoma progression.	RELN LTBP2 HCFC1 PLXNA2	7.27e-04	175	80	4	28071719
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	EYA4 RAPGEF6 DOCK7 ANKRD17 SRPK1 PZP HCFC1	7.53e-04	650	80	7	38777146
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	CEP350 ZC3H7A AMER1 OFD1 TRIO GCLM LRRCC1 FAM110B	7.75e-04	853	80	8	28718761
Pubmed	Previously associated type 2 diabetes variants may interact with physical activity to modify the risk of impaired glucose regulation and type 2 diabetes: a study of 16,003 Swedish adults.	THADA CDKAL1	7.81e-04	18	80	2	19324937
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	EPC2 FOXN2 EYA4 ARID4B ANKRD17 REL MDM4 HCFC1	7.99e-04	857	80	8	25609649
Pubmed	Clinical risk factors, DNA variants, and the development of type 2 diabetes.	THADA CDKAL1	8.71e-04	19	80	2	19020324
Pubmed	Risk prediction of prevalent diabetes in a Swiss population using a weighted genetic score--the CoLaus Study.	THADA CDKAL1	8.71e-04	19	80	2	19139842
Pubmed	New gene functions in megakaryopoiesis and platelet formation.	THADA DOCK8 AKAP10	8.79e-04	81	80	3	22139419
Pubmed	Utility of genetic and non-genetic risk factors in prediction of type 2 diabetes: Whitehall II prospective cohort study.	THADA CDKAL1	9.66e-04	20	80	2	20075150
Pubmed	PPARG, KCNJ11, CDKAL1, CDKN2A-CDKN2B, IDE-KIF11-HHEX, IGF2BP2 and SLC30A8 are associated with type 2 diabetes in a Chinese population.	THADA CDKAL1	9.66e-04	20	80	2	19862325
Pubmed	Examination of all type 2 diabetes GWAS loci reveals HHEX-IDE as a locus influencing pediatric BMI.	THADA CDKAL1	9.66e-04	20	80	2	19933996
Pubmed	Glomerulocystic kidney disease in mice with a targeted inactivation of Wwtr1.	OFD1 PKHD1	9.66e-04	20	80	2	17251353
Pubmed	Assembly of the WHIP-TRIM14-PPP6C Mitochondrial Complex Promotes RIG-I-Mediated Antiviral Signaling.	GCLM PHF11 LARP4 HCFC1 CDKAL1	1.03e-03	332	80	5	29053956
Pubmed	Genotype score in addition to common risk factors for prediction of type 2 diabetes.	THADA CDKAL1	1.07e-03	21	80	2	19020323
Pubmed	Assessing the combined impact of 18 common genetic variants of modest effect sizes on type 2 diabetes risk.	THADA CDKAL1	1.07e-03	21	80	2	18591388
Pubmed	Underlying genetic models of inheritance in established type 2 diabetes associations.	THADA CDKAL1	1.07e-03	21	80	2	19602701
Pubmed	SEMA6A drives GnRH neuron-dependent puberty onset by tuning median eminence vascular permeability.	PLXNA4 PLXNA2	1.07e-03	21	80	2	38062045
Pubmed	Loss of Zeb2 in mesenchyme-derived nephrons causes primary glomerulocystic disease.	OFD1 PKHD1	1.07e-03	21	80	2	27591083
Pubmed	Polygenic risk variants for type 2 diabetes susceptibility modify age at diagnosis in monogenic HNF1A diabetes.	THADA CDKAL1	1.17e-03	22	80	2	19794065
Interaction	CEP85 interactions	CEP350 ZC3H7A EYA4 OFD1 SEC16A ANKRD17 CCDC6	4.49e-06	169	79	7	int:CEP85
Interaction	YWHAH interactions	CEP350 RAPGEF6 AMER1 HIVEP1 OFD1 TRIO SEC16A DOCK7 ANKRD17 RIMS1 ITPRID2 CCDC6 MDM4 ATXN1L TRAK1 FAM110B	4.75e-06	1102	79	16	int:YWHAH
Cytoband	2q23.1	EPC2 MBD5	4.48e-05	6	80	2	2q23.1
Cytoband	1q32.2	SYT14 PLXNA2	1.02e-03	27	80	2	1q32.2
GeneFamily	Plexins	PLXNA4 PLXNA2	2.35e-04	9	47	2	683
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	CEP350 PCNX2 HIVEP3 FOXN2 RAPGEF6 ARID4B OFD1 DOCK8 RNF19A PHF11 SENP6 AKAP10 GPATCH8 TNFRSF1B KAT6B MDM4 PTGER4	2.09e-06	1492	80	17	M40023
Coexpression	GSE28408_LY6G_POS_VS_NEG_DC_UP	PCNX2 RAPGEF6 OFD1 SENP6 AKAP10 PTGER4 TRAK1	2.43e-06	197	80	7	M9547
Coexpression	GSE32901_TH1_VS_TH17_NEG_CD4_TCELL_UP	ANKRD17 IRAK3 GPATCH8 ZSWIM1 LARP4 OC90	3.08e-06	131	80	6	M8922
Coexpression	GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_MAC_DN	HIVEP1 BARD1 AKAP10 GPATCH8 KAT6B HCFC1	3.44e-05	200	80	6	M5169
Coexpression	GSE40068_BCL6_POS_VS_NEG_CXCR5_POS_TFH_DN	ADGB THADA RAPGEF6 AMER1 TRIO SENP6	3.44e-05	200	80	6	M9260
Coexpression	GSE40068_CXCR5POS_BCL6POS_TFH_VS_CXCR5NEG_BCL6NEG_CD4_TCELL_UP	AMER1 ARID4B TRIO SENP6 IRAK3 ATXN1L	3.44e-05	200	80	6	M9258
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	CEP350 HIVEP1 TRIO BARD1 ANKRD17 AKAP10 GPATCH8 CCDC6 KAT6B LARP4 TRAK1	5.67e-05	856	80	11	M4500
CoexpressionAtlas	dev gonad_e11.5_F_GonMes_Sma_top-relative-expression-ranked_1000	EPC2 CSRNP1 AMER1 HIVEP1 RNF19A AFF3 PLXNA4 REL ST6GAL1 LRRC4C KAT6B PTGER4 PLXNA2	1.01e-05	858	76	13	gudmap_dev gonad_e11.5_F_GonMes_Sma_1000
CoexpressionAtlas	dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000	EAF2 OFD1 GCLM ZGRF1 PHF11 SYT14 BARD1 REL GPATCH8 TAF4B LARP4 HCFC1	3.24e-05	820	76	12	gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000
CoexpressionAtlas	Myeloid Cells, DC.IIhilang+103-11b+.SLN, MHCIIhi CD11c+ Langerin+ CD103- CD11b+, Lymph Node, avg-3	CEP350 HIVEP1 TRIO RNF19A DOCK7 REL TNFRSF1B PTGER4	1.10e-04	411	76	8	GSM538271_500
CoexpressionAtlas	Myeloid Cells, DC.IIhilang-103-11b+.SLN, MHCIIhi CD11c+ Langerin- CD103- CD11b+, Lymph Node, avg-3	HIVEP1 RNF19A DOCK7 IRAK3 REL ITPRID2 TNFRSF1B PTGER4	1.10e-04	411	76	8	GSM538274_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_1000	CEP350 EYA4 TRIO KIAA1958 AKAP10 GPATCH8 PLXNA2	1.27e-04	312	76	7	gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k2
ToppCell	Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	EYA4 PLXNA4 LRRC4B LTBP2 TACR1 SCARA3	5.14e-07	164	80	6	e3983f655cdba308fb192182829f17bef99ce0ba
ToppCell	droplet-Lung-LUNG-1m-Myeloid-Ccr7+_Dendritic\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZNF180 PHF11 PLXNA4 BARD1 PTGER4 CDKAL1	7.28e-07	174	80	6	7be0c6248e77f2d0260b852b01e17892f7828f1b
ToppCell	droplet-Lung-1m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ZNF180 PHF11 PLXNA4 BARD1 PTGER4 CDKAL1	7.52e-07	175	80	6	1b910c08d2bfbcc77431ee66103e63a11a9d39fe
ToppCell	COPD-Lymphoid-B\|Lymphoid / Disease state, Lineage and Cell class	HIVEP1 TRIO AFF3 ST6GAL1 TRAK1 PARP15	1.21e-06	190	80	6	1e85ee686ff6dd27c69415d524d54fa825b1daad
ToppCell	control-Lymphocytic-B_cells_1\|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	EAF2 TRIO AFF3 REL TRAK1 PARP15	1.41e-06	195	80	6	ff7956624b36df34e55295b295a71585accf07bd
ToppCell	Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-B_lymphocytic-memory_B_cell\|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	AFF3 ST6GAL1 MDM4 TRAK1 PARP15	8.88e-06	155	80	5	d336559092563b0d7776eef873f1d2759aca45f7
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TMEM266 IRAK3 LRRC4B PZP PARP15	1.47e-05	172	80	5	3a37569a5902f3c65ff8d3912421309a8c82ee9b
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic-Mast_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TMEM266 IRAK3 LRRC4B PZP PARP15	1.47e-05	172	80	5	cc9d9dae290f11f8c348c78228af4e49469dc93b
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	FOXN2 ARID4B TRIO AFF3 CCDC6	1.51e-05	173	80	5	d56e337eae727a29cd53cfd628e1b3c0a98e1f51
ToppCell	3'-Adult-SmallIntestine-Hematopoietic-B_cells-Memory_B\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DOCK8 AFF3 REL ST6GAL1 TAF4B	1.69e-05	177	80	5	0d1c39e99144fdb9c7f6f98a1ade41c73db45b65
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PLXNA4 LTBP2 RIMS1 TMEM132B SCARA3	1.78e-05	179	80	5	02c90d8306016365ed811f0c63cfb3ac7b85464c
ToppCell	COPD-Myeloid-pDC\|Myeloid / Disease state, Lineage and Cell class	HIVEP3 HIVEP1 OFD1 AFF3 PLXNA4	1.78e-05	179	80	5	29b058c5e33fda9f0d738c074bdb67ff16b9b6d5
ToppCell	Children_(3_yrs)-Mesenchymal-myofibroblast_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	EYA4 PLXNA4 LTBP2 SCARA3 TMPRSS11A	1.83e-05	180	80	5	01f2e5d96016823482f89ba503d007d4bd88eeac
ToppCell	3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	HIVEP1 AFF3 REL TAF4B PARP15	1.88e-05	181	80	5	d66838fca0429cad2079cd8d92a5cd33eb0d3522
ToppCell	Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	EYA4 TRIO PLXNA4 LTBP2 SCARA3	1.93e-05	182	80	5	ed6ae0fd8653f213fe29906a6a4e0729a62e1b75
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PLXNA4 LTBP2 RIMS1 TMEM132B SCARA3	1.98e-05	183	80	5	7eae9b3b4d1c9b135fa7cff348393d4adec474b4
ToppCell	LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PLXNA4 LRRC4B RIMS1 TMEM132B SCARA3	1.98e-05	183	80	5	12daaea821e49bc94a01e2496331e92a80d27339
ToppCell	3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	HIVEP1 AFF3 REL TAF4B PARP15	2.09e-05	185	80	5	e913c64f9b4873443d88dce270f0b7b6d1b4cbce
ToppCell	Control-Lymphoid-T_Regulatory\|Lymphoid / Disease state, Lineage and Cell class	ZC3H7A THADA RAPGEF6 HIVEP1 CDKAL1	2.09e-05	185	80	5	e481cacda0b6b25f5f0062b962df9a442053ac30
ToppCell	LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PLXNA4 RIMS1 PZP TMEM132B SCARA3	2.09e-05	185	80	5	e64e8c98dd88d91f6501d3fb10b60fd2f3c90af3
ToppCell	COVID-19-lung-B_cells\|COVID-19 / Disease (COVID-19 only), tissue and cell type	EAF2 DOCK8 AFF3 ST6GAL1 PARP15	2.09e-05	185	80	5	e8f1ad580f19705b5ca1d7d8867b2125f4891684
ToppCell	BL-critical-LOC-Lymphoid-B_cell\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	EAF2 AFF3 ST6GAL1 LRRC4C PARP15	2.14e-05	186	80	5	27d4c38b180e4ce2bf3e7c4ad3db3a2ffca05ca8
ToppCell	Control-Lymphoid-B\|Lymphoid / Disease state, Lineage and Cell class	TRIO AFF3 ST6GAL1 TRAK1 PARP15	2.20e-05	187	80	5	4e64be635f445276e71f2937f33f041c3a4204ab
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	EYA4 DOCK7 ST6GAL1 TRAK1 FAM110B	2.20e-05	187	80	5	2d17408b3b5f09d135084fd7ccce98e6b5ca632b
ToppCell	IPF-Lymphoid-B\|Lymphoid / Disease state, Lineage and Cell class	TRIO AFF3 ST6GAL1 TRAK1 PARP15	2.20e-05	187	80	5	af1327559f7e01bec070881cae52834917c3da65
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	AFF3 REL ST6GAL1 MDM4 PARP15	2.25e-05	188	80	5	d8decd9b5967873ca8320c2f9f07365f163c777f
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	EYA4 DOCK7 ST6GAL1 FBN3 FAM110B	2.25e-05	188	80	5	58ccb31cdf43167872ef0fc737e6f9c51ee2e060
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TRIO PKHD1 LRRC4C SCARA3 CDKAL1	2.25e-05	188	80	5	63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	EYA4 PLXNA4 LTBP2 RIMS1 PLXNA2	2.25e-05	188	80	5	3004e961d214919e08c7cd5f10c3de5cf85b35a3
ToppCell	Smart-seq2-spleen_(Smart-seq2)\|Smart-seq2 / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	CSRNP1 AFF3 REL ST6GAL1 PARP15	2.31e-05	189	80	5	b0244a9d1b5c8ad4708750b691184f3491b13900
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-B_cell\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	EAF2 TRIO AFF3 ST6GAL1 TRAK1	2.31e-05	189	80	5	886dceacf96e2b6750c146a381da0bf96a2bb15b
ToppCell	CTRL-Lymphoid-B_cell\|Lymphoid / Disease state, Lineage and Cell class	TRIO AFF3 ST6GAL1 TRAK1 PARP15	2.31e-05	189	80	5	14f3a8c0f4f057ad4e6839b4c3eeaf956d6dc92e
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	EAF2 TRIO AFF3 ST6GAL1 TRAK1	2.31e-05	189	80	5	5f1f4321939877374a8ee13de93f2d1390af8e2e
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	ZC3H7A THADA RNF19A CCDC6 PTGER4	2.37e-05	190	80	5	91ba66d4b56c59523485b17738e93f14bb00afa4
ToppCell	Fetal_29-31_weeks-Immune-B_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	AFF3 REL ST6GAL1 TRAK1 PARP15	2.37e-05	190	80	5	424550418c1bd4eb070cf3c41cf09fa9d89aef37
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	AFF3 REL ST6GAL1 MDM4 PARP15	2.49e-05	192	80	5	446c61c0d6ba89c619efe87ee495951299953981
ToppCell	wk_08-11-Mesenchymal-Myofibro_&_SMC-Early_airway_SMC_1\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	CSRNP1 EYA4 PLXNA4 LTBP2 TACR1	2.49e-05	192	80	5	7ae3e1ca8bfc078c0e12a1595ecb0e343dab5d2f
ToppCell	B_cells-Memory_B_cells\|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	DOCK8 AFF3 REL ST6GAL1 PARP15	2.49e-05	192	80	5	eef591095921ede098f41a2b81897b18915bb753
ToppCell	moderate-Lymphoid-B_cell\|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	EAF2 AFF3 REL ST6GAL1 PARP15	2.49e-05	192	80	5	ae3727503c3b9f4695e565fd3161cc33b898f349
ToppCell	renal_cortex_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	TRIO PKHD1 ANKRD17 MBD5 CDKAL1	2.49e-05	192	80	5	e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	TRIO AFF3 REL CCDC6 PARP15	2.55e-05	193	80	5	08696a99309f5b088692ddac8cca35413b5e810d
ToppCell	367C-Myeloid-Dendritic-cDC2\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	CSRNP1 OFD1 AFF3 REL PTGER4	2.55e-05	193	80	5	940e9a419d0de1f9e72b5cc9c86684057003be58
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	EAF2 AFF3 REL ST6GAL1 PARP15	2.68e-05	195	80	5	0c49d22c348aec6d8a1a976e7c88d0a3b48a4244
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Monocytic-Monocyte-derived_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK8 AFF3 IRAK3 REL TNFRSF1B	2.68e-05	195	80	5	62dc745e1aa3e2e58afa16c7bb2cf9b03d4e8105
ToppCell	11.5-Distal-Mesenchymal-Airway_Smooth_Muscle\|Distal / Age, Tissue, Lineage and Cell class	EYA4 PLXNA4 LTBP2 TACR1 PLXNA2	2.75e-05	196	80	5	05530fe7a5681c2f39b95016cd22ef99d6ac0430
ToppCell	Bronchial-10x5prime-Immune_Lymphocytic-B-B_cell\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	EAF2 AFF3 ST6GAL1 TAF4B PARP15	2.75e-05	196	80	5	e9fe5090452ffdde4bb81b62d57037d823281d00
ToppCell	Bronchial-10x5prime-Immune_Lymphocytic-B-B_cell-B_mature\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	EAF2 AFF3 ST6GAL1 TAF4B PARP15	2.75e-05	196	80	5	c2e17f3b2217f20bd7f28a1db4aa7d9a95c52a9c
ToppCell	Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-B_lymphocytic\|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	EAF2 AFF3 REL ST6GAL1 PARP15	2.82e-05	197	80	5	fa3cc33c975648172feabb485c3bdd087f1f8ea7
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic-Monocyte-derived_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK8 AFF3 IRAK3 REL TNFRSF1B	2.82e-05	197	80	5	826cc6baafab13e7ef5cfcf28cd79d0fbf3af38d
ToppCell	normal_Lymph_Node-Myeloid_cells-CD1c+_DCs\|Myeloid_cells / Location, Cell class and cell subclass	CSRNP1 AFF3 REL MDM4 PTGER4	2.82e-05	197	80	5	2b3cd318c988364adcba4441444045914d58fe46
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	HIVEP3 CSRNP1 IRAK3 ST6GAL1 TACR1	2.89e-05	198	80	5	92416e65a0dc1a4bf931833407620ea05d362f56
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_B\|lymph-node_spleen / Manually curated celltypes from each tissue	EAF2 AFF3 REL ST6GAL1 PARP15	2.89e-05	198	80	5	1780fa1725a321041094e8c4430673c0a4f3d407
ToppCell	severe-B_intermediate\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	EAF2 AFF3 REL CCDC6 PARP15	2.96e-05	199	80	5	17283d75a2a900369f63ed02996e7ede97f46140
ToppCell	LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	PLXNA4 LTBP2 PZP TMEM132B SCARA3	2.96e-05	199	80	5	6b3a0e5d52a30d0eed30e6a670f5b53bc233f70c
ToppCell	10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-B_lymphocytic\|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	EAF2 AFF3 REL ST6GAL1 PARP15	2.96e-05	199	80	5	1aa963ed5205d6d52262b1597a5d08707a95c3ca
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuronal\|GW16 / Sample Type, Dataset, Time_group, and Cell type.	HIVEP3 AFF3 PLXNA4 PLXNA2 FAM110B	3.03e-05	200	80	5	84e4565d28a02700bf7f6730d1b3a58744ca0aea
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW16-Neuronal\|GW16 / Sample Type, Dataset, Time_group, and Cell type.	HIVEP3 AFF3 PLXNA4 PLXNA2 FAM110B	3.03e-05	200	80	5	1decf1d2cba5ebfd3e5cd4bcd637db8f193033ce
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW23-Mesenchymal\|GW23 / Sample Type, Dataset, Time_group, and Cell type.	CSRNP1 WIPI1 DOCK8 TNFRSF1B PTGER4	3.03e-05	200	80	5	0eccf41edefc3b8b5d0316f57d5ba572949aec2b
ToppCell	Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|Control_saline / Treatment groups by lineage, cell group, cell type	PLXNA4 LTBP2 RIMS1 PZP SCARA3	3.03e-05	200	80	5	a799fc7bb83ad0524362cb5010df949741fb7bf3
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	CEP350 ARID4B DOCK8 REL MDM4	3.03e-05	200	80	5	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	10x5'-GI_large-bowel-Lymphocytic_T_CD4\|GI_large-bowel / Manually curated celltypes from each tissue	PCNX2 CSRNP1 RAPGEF6 RNF19A TNFRSF1B	3.03e-05	200	80	5	42403d59b65d4b3ba6aa4aaf2d7252176067fba5
ToppCell	LPS_only-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|LPS_only / Treatment groups by lineage, cell group, cell type	PLXNA4 LRRC4B LTBP2 PZP SCARA3	3.03e-05	200	80	5	a9ff3210127000b3dd9e97136163c98c2b0817d7
ToppCell	mild-B_naive\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	EAF2 AFF3 REL MDM4 PARP15	3.03e-05	200	80	5	222789b897e2a683bbfd1d00b6fd8705015d90df
ToppCell	Posterior_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	EYA4 CCDC168 TACR1 OC90	7.87e-05	126	80	4	84dce108561d4b745d19250c2ac0667d9e4ea17d
ToppCell	TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Diffuse\|TCGA-Stomach / Sample_Type by Project: Shred V9	IL31RA AFF3 PZP PARP15	8.62e-05	129	80	4	7d537680b0dfb764f7914d0475c66b678b5cb8d2
ToppCell	Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	EYA4 PLXNA4 LTBP2 SCARA3	1.66e-04	153	80	4	1524557514668f515ac1bbe847611f564b265b42
ToppCell	COVID-19-kidney-Technical/muscle_(Mes)\|kidney / Disease (COVID-19 only), tissue and cell type	RELN RIMS1 LRRC4C TMEM132B	1.93e-04	159	80	4	5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d
ToppCell	Adult-Mesenchymal-airway_smooth_muscle_cell-D122\|Adult / Lineage, Cell type, age group and donor	AMER1 LRRC4B LTBP2 HCFC1	2.02e-04	161	80	4	64891f6f2ee1693c8481e951b9346e2f92d602e3
ToppCell	10x5'-GI_large-bowel-Lymphocytic_T_CD4-Tregs\|GI_large-bowel / Manually curated celltypes from each tissue	PCNX2 THADA RNF19A PKHD1	2.07e-04	162	80	4	9a5e65c45f73a6a685b8362aa2e6aea77181caa3
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	FOXN2 TRIO AFF3 CCDC6	2.12e-04	163	80	4	6bed27d2f67a430a847da5eb47878d14b4949c45
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-3m-Lymphocytic-T_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DOCK8 REL TNFRSF1B PTGER4	2.12e-04	163	80	4	8028636632c168dc50731d0ebecaf88a70daf81d
ToppCell	10x5'-bone_marrow-Lymphocytic_B-ABC_aged-B_memory\|bone_marrow / Manually curated celltypes from each tissue	AFF3 ST6GAL1 LRRC4C PARP15	2.17e-04	164	80	4	746833f74095c0f25ce76baf1069f1848c231933
ToppCell	Adult-Epithelial-lung_goblet_cell-D175\|Adult / Lineage, Cell type, age group and donor	EYA4 TACR1 RIMS1 TMPRSS11A	2.17e-04	164	80	4	6e6aedb61f8e195d52e028fdda750a29bb14e57e
ToppCell	facs-Lung-3m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	IL31RA DOCK8 REL TNFRSF1B	2.17e-04	164	80	4	11dfd84f5fb90de330858e1e852848832734e004
ToppCell	metastatic_Brain-Myeloid_cells-pDCs\|metastatic_Brain / Location, Cell class and cell subclass	HIVEP1 EAF2 AFF3 PLXNA4	2.17e-04	164	80	4	06db4cc064f0765c481ce880207823872c27bfa9
ToppCell	droplet-Bladder-BLADDER-1m-Epithelial-basal_bladder_epithelial_cell_(Krt5+)\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GCLM PKHD1 KIAA1958 CCDC6	2.22e-04	165	80	4	936581de8fcd097401707438b9bbe89dd4e3e247
ToppCell	normal_Lymph_Node-T/NK_cells-CD8+/CD4+_Mixed_Th\|T/NK_cells / Location, Cell class and cell subclass	CSRNP1 RNF19A REL PTGER4	2.27e-04	166	80	4	d638d356592325cded4a6cb549041cf2f8d3e62c
ToppCell	facs-Brain_Non-Myeloid-Striatum-3m-Neuronal-neuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AFF3 PLXNA4 TACR1 GPR101	2.27e-04	166	80	4	548d0d6c0ffd564036ddba78620734220ebb73d7
ToppCell	facs-Brain_Non-Myeloid-Striatum-3m-Neuronal-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AFF3 PLXNA4 TACR1 GPR101	2.27e-04	166	80	4	80e164a89d22098cabe4a99a78283ba69ea0561e
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4-5_RORB_AIM2\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	RELN EYA4 BARD1 LRRC4C	2.32e-04	167	80	4	4c8bb68ee2bf7b794940b34df96f38f3f69507e9
ToppCell	Control-B_cells-Activated_B_cells\|Control / group, cell type (main and fine annotations)	DOCK8 AFF3 ST6GAL1 PARP15	2.38e-04	168	80	4	a7159a35fe37f8c241cf8d391debe271e0698105
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_B-ABC_aged-B_naive\|lymph-node_spleen / Manually curated celltypes from each tissue	HIVEP3 EAF2 AFF3 PARP15	2.38e-04	168	80	4	494d5a11154ff22fedb25f4036d730cef376da60
ToppCell	368C-Lymphocytic-NK_cells-NK_cell_E\|368C / Donor, Lineage, Cell class and subclass (all cells)	OFD1 AFF3 MBD5 CDKAL1	2.43e-04	169	80	4	0d96c0b4fd26fbc0bf44ff7bed2936eebcc55b74
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	EYA4 PLXNA4 IRAK3 PTGER4	2.43e-04	169	80	4	a84490724a206c9bbb145f7ce08613f91d100ac4
ToppCell	wk_08-11-Mesenchymal-Myofibro_&_SMC-Myofibro_2\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	EYA4 AMER1 PLXNA4 TACR1	2.49e-04	170	80	4	fefb07a7e308b620f946b9ff2b01e1796446fe38
ToppCell	droplet-Lung-21m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l48\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	EPC2 AFF3 TAF4B MDM4	2.49e-04	170	80	4	070d8683d1a5cc7d594ff0453c961a9bf982c2d0
ToppCell	normal-na-Lymphocytic_T-T4_em-male\|normal / PBMC cell types (v2) per disease, treatment status, and sex	ARID4B RNF19A KAT6B PTGER4	2.54e-04	171	80	4	61318a7aaf3bd8bdd28f8a8614ab4fdf2964b3a3
ToppCell	COVID-19-kidney-Bcells\|COVID-19 / Disease (COVID-19 only), tissue and cell type	AFF3 REL ST6GAL1 PARP15	2.54e-04	171	80	4	8e8fb79968b1a5c34d1d9cad7f9155fabfdb7cc7
ToppCell	facs-Lung-nan-3m-Lymphocytic-B_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EAF2 REL ST6GAL1 TMEM132B	2.54e-04	171	80	4	a31c23406cf6d6a17358a8fb41d392a7fb0306e0
ToppCell	facs-Lung-nan-3m-Lymphocytic-B_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EAF2 REL ST6GAL1 TMEM132B	2.54e-04	171	80	4	43d8fd9b9546e84a652564fe96b514b34b06262b
ToppCell	MS-CD8-proli_CD4\|MS / Condition, Cell_class and T cell subcluster	AMER1 AKAP10 ZSWIM1 TMEM132B	2.60e-04	172	80	4	0b6dd257110b3f17fa71ab18a165b091a9d5ae9a
ToppCell	Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	EYA4 LTBP2 SCARA3 TMPRSS11A	2.66e-04	173	80	4	1f16d47f5548e257e4b17f8070c5619780a9c5fd
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4-5_RORB_ASCL1\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	RELN EYA4 BARD1 LRRC4C	2.66e-04	173	80	4	2e35bf2b5534a289d93a09faae660f665c131062
ToppCell	356C-Fibroblasts-Fibroblast-B_(Myofibroblast)\|356C / Donor, Lineage, Cell class and subclass (all cells)	LTBP2 LRRC4C PZP SCARA3	2.66e-04	173	80	4	75e26a65071b0d2f30ed0b2aa9859c488f5cf362
ToppCell	Mild/Remission-B_naive-8\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	ARID4B AFF3 REL MDM4	2.66e-04	173	80	4	694d02c4d2dc2de4b344544f9124fec40fcf7d8f
ToppCell	356C-Fibroblasts-Fibroblast-B_(Myofibroblast)-\|356C / Donor, Lineage, Cell class and subclass (all cells)	LTBP2 LRRC4C PZP SCARA3	2.66e-04	173	80	4	26e2e674f5d312fa8f61c11b553dc6101f063b16
ToppCell	droplet-Lung-21m-Hematologic-lymphocytic-plasma_cell-plasma_cell\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	RELN WIPI1 EAF2 ST6GAL1	2.78e-04	175	80	4	28b29f844fa46fe579ddc19039fb2d9dc5f48f3b
ToppCell	3'-Parenchyma_lung-Epithelial-Epithelial_transtional-epithelial_cell_of_lung-Transitional_Club-AT2-Transitional_Club-AT2_L.0.4.1.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	HIVEP1 TRIO TMEM132B SCARA3	2.78e-04	175	80	4	dbd9dac129fb6ae5f55e7b96d04b37585458dc4a
ToppCell	droplet-Lung-21m-Hematologic-lymphocytic-plasma_cell\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	RELN WIPI1 EAF2 ST6GAL1	2.78e-04	175	80	4	ac96ca9ca309b0d72a2f5af6a3b02c7f80755750
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-B_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK8 AFF3 REL PARP15	2.84e-04	176	80	4	274458d80f9f3f080248cbf64e4784ef351e7254
Disease	level of Phosphatidylcholine (18:2_18:2) in blood serum	DOCK7 PLXNA4	1.03e-04	6	78	2	OBA_2045106
Disease	Neurodevelopmental Disorders	HIVEP3 TRIO DOCK8 RIMS1	1.10e-04	93	78	4	C1535926
Disease	cystitis (implicated_via_orthology)	TACR1 PTGER4	1.91e-04	8	78	2	DOID:1679 (implicated_via_orthology)
Disease	pulse pressure measurement	HIVEP3 EPC2 LTBP2 GPATCH8 NEURL1B CCDC6 GPR101 MBD5 LARP4 HCFC1 CDKAL1 TRAK1	2.81e-04	1392	78	12	EFO_0005763
Disease	smoking behavior	SYT14 PLXNA4 PKHD1 LRRC4C TMEM132B PLXNA2	2.91e-04	341	78	6	EFO_0004318
Disease	sugar consumption measurement	WIPI1 TRIO PKHD1 PLXNA2	2.94e-04	120	78	4	EFO_0010158
Disease	Diabetes Mellitus, Non-Insulin-Dependent	EPC2 THADA ST6GAL1 TNFRSF1B CDKAL1	3.05e-04	221	78	5	C0011860
Disease	intraocular pressure measurement	HIVEP3 RELN THADA TTC41P AFF3 PKHD1 LTBP2	4.01e-04	509	78	7	EFO_0004695
Disease	diet measurement	FOXN2 THADA TRIO PKHD1 AKAP10 RIMS1 LRRC4C GPATCH8 MBD5 FAM110B	4.35e-04	1049	78	10	EFO_0008111
Disease	juvenile polyposis syndrome (implicated_via_orthology)	HIVEP3 HIVEP1	5.28e-04	13	78	2	DOID:0050787 (implicated_via_orthology)
Disease	response to ketamine	DOCK8 TMEM266 IRAK3	8.21e-04	69	78	3	EFO_0009748
Disease	Manic Disorder	RELN TACR1 RIMS1	8.92e-04	71	78	3	C0024713
Disease	Alzheimer disease, polygenic risk score	FOXN2 ZNF180 PKHD1 AKAP10 RIMS1 LARP4 SCARA3	9.19e-04	586	78	7	EFO_0030082, MONDO_0004975
Disease	osteoporosis (implicated_via_orthology)	IRAK3 PTGER4	1.15e-03	19	78	2	DOID:11476 (implicated_via_orthology)
Disease	diet measurement, HOMA-B	PCNX2 PLXNA4	1.15e-03	19	78	2	EFO_0004469, EFO_0008111
Disease	ankylosing spondylitis (is_implicated_in)	TNFRSF1B PTGER4	1.15e-03	19	78	2	DOID:7147 (is_implicated_in)
Disease	Manic	RELN TACR1 RIMS1	1.17e-03	78	78	3	C0338831
Disease	Depression, Bipolar	RELN TACR1 RIMS1	1.22e-03	79	78	3	C0005587
Disease	dilated cardiomyopathy (implicated_via_orthology)	LTBP2 MDM4 PTGER4	1.26e-03	80	78	3	DOID:12930 (implicated_via_orthology)
Disease	selenium measurement, response to dietary selenium supplementation	ZC3H7A TRIO	1.27e-03	20	78	2	EFO_0006331, EFO_0600021
Disease	cerebellar cortex volume measurement	LRRC4C VSIG10L2	1.40e-03	21	78	2	EFO_0010291
Disease	Hodgkin Disease	RELN REL	1.54e-03	22	78	2	C0019829
Disease	alcohol consumption measurement	FOXN2 RELN AFF3 SYT14 PLXNA4 PKHD1 SENP6 KLF18 LRRC4C PLXNA2	1.57e-03	1242	78	10	EFO_0007878
Disease	DNA methylation	FOXN2 THADA TRIO PLXNA4 PKHD1 RIMS1 LRRC4C	1.76e-03	656	78	7	GO_0006306
Disease	eosinophil count	HIVEP3 THADA RAPGEF6 HIVEP1 PHF11 SEC16A LTBP2 NEURL1B TNFRSF1B MBD5 MDM4	1.80e-03	1488	78	11	EFO_0004842
Disease	low density lipoprotein cholesterol measurement, response to escitalopram, response to citalopram	RELN RIMS1	1.83e-03	24	78	2	EFO_0004611, EFO_0006329, EFO_0007871
Disease	congestive heart failure (is_implicated_in)	EYA4 TNFRSF1B	2.32e-03	27	78	2	DOID:6000 (is_implicated_in)
Disease	retinal degeneration (biomarker_via_orthology)	OFD1 BARD1	2.49e-03	28	78	2	DOID:8466 (biomarker_via_orthology)

Protein segments in the cluster

Peptide	Gene	Start	Entry
ATSTSNTLSANHCNM	AFF3	846	P51826
SLCMENSSNSSSDED	ARID4B	851	Q4LE39
SSTSDCMSKTLDSAS	EPC2	621	Q52LR7
SSSASHCSVMNTGQR	BARD1	551	Q99728
TTTNCFSSNTRKMTS	ADGRG4	1786	Q8IZF6
QSLSDCSSAIQTSHM	ADGB	401	Q8N7X0
ISANMDSFSSSRTAT	AKAP10	76	O43572
NSSSSTRSAVDMACS	GCLM	101	P48507
NLFSSMSCSSDSDSS	AMER1	781	Q5JTC6
MSCSSDSDSSFTQNL	AMER1	786	Q5JTC6
NSSSSAAMQSSCSST	CCDC6	16	Q16204
NMRISSCSDESSNSN	ANKRD17	1616	O75179
QTMCRSLSSSSEAVT	FBN3	2306	Q75N90
TFSSMTCASGANVSE	PZP	921	P20742
SCNMETQTSSTFNRD	OFD1	156	O75665
SSSLTQSSCAVTQQM	KAT6B	1711	Q8WYB5
SASITMASFSSEDCS	KIAA1107	1251	Q9UPP5
CQTRQTSATSTTMTV	HCFC1	1166	P51610
SASLNFQSTFSMTTC	PARP15	466	Q460N3
MTSFSTSAQCSTSDS	MDM4	1	O15151
DNCTTNSSTSENRAS	IL31RA	66	Q8NI17
NSCSSDMTDSSTASS	CSRNP1	346	Q96S65
VTSEDMGRTTSCSTN	ATXN1L	21	P0C7T5
CSSQSSEESSRQSCM	ARNTL2	486	Q8WYA1
QMCESNSSKETSLAT	GPATCH8	506	Q9UKJ3
CLSQAREMQVSSSST	PCNX2	736	A6NKB5
LSVVAQTFMDSCSTS	PLXNA2	1771	O75051
LSVVAQTFMDSCSTS	PLXNA4	1771	Q9HCM2
QHCSDSQRTSSAMSG	PTGER4	361	P35408
CMVSNSVGNTTASAT	LRRC4C	426	Q9HCJ2
LEHQSCTINMTSSSS	IRAK3	321	Q9Y616
MTSTCTNSTRESNSS	GPR101	1	Q96P66
TNSTRESNSSHTCMP	GPR101	6	Q96P66
TAAECMTSASFNQSL	OC90	396	Q02509
QAMGSSADSCDSETT	ITPRID2	531	P28290
IGSMSQTDSCNSDLS	RELN	3336	P78509
ASRLSSTSFMSEQSE	RIMS1	1356	Q86UR5
CTESDVSQSQNSRSM	EYA4	16	O95677
DRSCNRMSSHTETSS	DOCK7	956	Q96N67
SSSMDVTRSQACATL	DOCK8	1516	Q8NF50
DQMSSCDSSSDSKSS	EAF2	171	Q96CJ1
HTSAASQCDSASSRM	CDKAL1	531	Q5VV42
TDSSSSDMQACSQDK	CEP350	956	Q5VT06
LSQQRCMNSTSSTED	LTBP2	1561	Q14767
QTECTSAQQLNMSTS	LARP4	531	Q71RC2
QSMSCQSSHLSSNST	MBD5	706	Q9P267
ASMISSDCEQSQDSN	FAM110B	311	Q8TC76
ASSMAAQRCASRSSV	FOXN2	306	P32314
TTSASNQTLCGEQMT	KLF18	281	A0A0U1RQI7
TSTSNQTLCGEQMTT	KLF18	576	A0A0U1RQI7
EQMTTSTSNQTLCGE	KLF18	586	A0A0U1RQI7
TTSASNQTLCGEQMT	KLF18	631	A0A0U1RQI7
GEQMTTSTSNQTLCE	KLF18	641	A0A0U1RQI7
MTTSTSNQTLCGEQT	KLF18	686	A0A0U1RQI7
TTSTSNQTLCGEQMT	KLF18	771	A0A0U1RQI7
TSNQTLCGEQMTTST	KLF18	816	A0A0U1RQI7
FCLSSSTQQELSDTM	CCDC168	3881	Q8NDH2
STTSRQISQEMGSCS	SCARA3	161	Q6AZY7
TTASTNMNASSSRSH	KIF28P	216	B7ZC32
CMVTNSAGNTTASAT	LRRC4B	436	Q9NT99
QQTSSDMVIATCTTT	TAF4B	346	Q92750
DSQMSVSEMSCSEST	SYT14	391	Q8NB59
TVTTAMSQENTCQST	THADA	1751	Q6YHU6
SRSSIVSNCSVDSMS	RAPGEF6	1271	Q8TEU7
IDNGSTQTSATLTCM	TMEM132B	341	Q14DG7
DLTSNCSSRSDSKTM	TACR1	381	P25103
CSSRSDSKTMTESFS	TACR1	386	P25103
MGSDSQSVSSSSTQD	ST6GAL1	56	P15907
ASMETLSASCLVNSS	PKHD1	2541	P08F94
VSDTMVCQSSSTVGQ	SRPK1	421	Q96SB4
CMSQTNSTFTFTTCR	TRAK1	661	Q9UPV9
AESFTNTRESTTTMS	TRAK1	721	Q9UPV9
MCTDKNSIFSTNTSS	RNF19A	101	Q9NV58
SRCSSMSSLSREVSQ	SEC16A	2291	O15027
DSDMTFSVNQSSSAS	NEURL1B	456	A8MQ27
AERLTASSCSMSSQS	HIVEP3	1921	Q5T1R4
SAQSSNTVSSAMCMN	TTC41P	1141	Q6P2S7
SSASEMESCSQNSSA	SENP6	806	Q9GZR1
LSNCSVNMMTTSSDS	REL	491	Q04864
CSFQENRDLMSSSTS	PHF11	311	Q9UIL8
CSETSHSSSLTQNMR	ZNF180	331	Q9UJW8
CSSLNSFSMSESKRD	ZC3H7A	356	Q8IWR0
SESSSSCEELNSEMT	ZGRF1	261	Q86YA3
SDHSSQCSSQASSTM	TNFRSF1B	391	P20333
QCSSQASSTMGDTDS	TNFRSF1B	396	P20333
SMDSQFLCASSNTET	WIPI1	241	Q5MNZ9
TSLQSTMCSATAGNL	ZSWIM1	196	Q9BR11
MCSASNSVNRLSSDG	VSIG10L2	216	P0DP72
CENVFSEMSQNSSLS	HIVEP1	1706	P15822
SSQTLGSSMDCSTAR	TMEM266	401	Q2M3C6
KDTDRMSTCSSASEQ	TRIO	2521	O75962
MSTCSSASEQSVQST	TRIO	2526	O75962
AMSSSTGELTVQASC	TMPRSS11A	161	Q6ZMR5
SLHSSSQTQMVDECS	KIAA1958	181	Q8N8K9
SDAVLTSFMSVCQSS	LRRCC1	266	Q9C099